Steven L. Stice
Fondatore presso Aruna Bio, Inc.
Profilo
Steven L.
Stice is the founder of Aruna Bio, Inc., a company founded in 2003, where he currently holds the title of Director & Chief Scientific Officer.
He also held the position of Director-Regenerative Bioscience Center at the University of Georgia.
Additionally, he worked as a Consultant at BresaGen, Inc. and as Chief Executive & Scientific Officer at Astellas Institute for Regenerative Medicine.
Posizioni attive di Steven L. Stice
| Società | Posizione | Inizio |
|---|---|---|
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Fondatore | 13/01/2010 |
Precedenti posizioni note di Steven L. Stice
| Società | Posizione | Fine |
|---|---|---|
| University of Georgia | Corporate Officer/Principal | 04/07/2011 |
| OCATA THERAPEUTICS INC | Amministratore Delegato | - |
| BresaGen, Inc. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
| BresaGen, Inc. | Commercial Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Borsa valori
- Insiders
- Steven L. Stice
